IVGAX
Price
$22.59
Change
-$0.40 (-1.74%)
Updated
Feb 21 closing price
Net Assets
157.69M
VVIAX
Price
$68.79
Change
-$0.81 (-1.16%)
Updated
Feb 21 closing price
Net Assets
192.55B
Ad is loading...

IVGAX vs VVIAX

Header iconIVGAX vs VVIAX Comparison
Open Charts IVGAX vs VVIAXBanner chart's image
VY® Invesco Growth and Income A
Price$22.59
Change-$0.40 (-1.74%)
VolumeN/A
Net Assets157.69M
Vanguard Value Index Adm
Price$68.79
Change-$0.81 (-1.16%)
VolumeN/A
Net Assets192.55B
IVGAX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IVGAX vs. VVIAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVGAX is a Hold and VVIAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 193B vs. IVGAX (158M). VVIAX pays higher dividends than IVGAX: VVIAX (2.36) vs IVGAX (1.23). IVGAX was incepted earlier than VVIAX: IVGAX (21 years) vs VVIAX (24 years). IVGAX has a lower initial minimum investment than VVIAX: IVGAX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 13.46 vs. IVGAX (2.77). VVIAX return over 5 years is better than : 47.22 vs. IVGAX (7.43).
IVGAXVVIAXIVGAX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years24 years-
Gain YTD3.7674.16490%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets158M193B0%
Annual Yield % from dividends1.232.3652%
Returns for 1 year2.7713.4621%
Returns for 3 years-10.2123.94-43%
Returns for 5 years7.4347.2216%
Returns for 10 years-16.60105.55-16%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EWBC93.89-3.23
-3.33%
East West Bancorp
SIGA5.91-0.22
-3.51%
SIGA Technologies
INTA66.11-3.25
-4.69%
Intapp
BMEA3.46-0.19
-5.21%
Biomea Fusion
CNSP3.23-0.52
-13.87%
CNS Pharmaceuticals Inc.